Several causes have been described for the aberrant accumulation of NRF2 in cancer cells, including somatic mutations in KEAP1 or NRF2 genes, sequestration of KEAP1 by p62/SQSTM1 and electrophilic attack of KEAP1 thiols by fumarate6–10. The gene discussed is SQSTM1; the disease is cancer.